Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2700375 | Saudi Journal of Ophthalmology | 2012 | 13 Pages |
Abstract
Many advances in the field of management of retinoblastoma emerged in the past few years. Patterns of presentation of retinoblastoma in the Middle East region differ from Western community. The use of enucleation as a radical method of eradicating advanced disease is not easily accepted by patient’s family. We still do see stage E, failed or resistant retinoblastoma and advanced extraocular disease ensues as a result of delayed enucleation decision. In this review, we discuss updates in management of retinoblastoma with its implication on patients in our part of the world. Identifying clinical and high risk characteristics is important prognostically and are discussed for further management of retinoblastoma cases.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ihab Saad Othman,